File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Modeling the economic burden of adult vaccine-preventable diseases in the United States

TitleModeling the economic burden of adult vaccine-preventable diseases in the United States
Authors
Issue Date2016
Citation
Health Affairs, 2016, v. 35, n. 11, p. 2124-2132 How to Cite?
AbstractVaccines save thousands of lives in the United States every year, but many adults remain unvaccinated. Low rates of vaccine uptake lead to costs to individuals and society in terms of deaths and disabilities, which are avoidable, and they create economic losses from doctor visits, hospitalizations, and lost income. To identify the magnitude of this problem, we calculated the current economic burden that is attributable to vaccine-preventable diseases among US adults. We estimated the total remaining economic burden at approximately $9 billion (plausibility range: $4.7-$15.2 billion) in a single year, 2015, from vaccine-preventable diseases related to ten vaccines recommended for adults ages nineteen and older. Unvaccinated individuals are responsible for almost 80 percent, or $7.1 billion, of the financial burden. These results not only indicate the potential economic benefit of increasing adult immunization uptake but also highlight the value of vaccines. Policies should focus on minimizing the negative externalities or spillover effects from the choice not to be vaccinated, while preserving patient autonomy.
Persistent Identifierhttp://hdl.handle.net/10722/327124
ISSN
2023 Impact Factor: 8.6
2023 SCImago Journal Rankings: 4.387
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorOzawa, Sachiko-
dc.contributor.authorPortnoy, Allison-
dc.contributor.authorGetaneh, Hiwote-
dc.contributor.authorClark, Samantha-
dc.contributor.authorKnoll, Maria-
dc.contributor.authorBishai, David-
dc.contributor.authorYang, H. Keri-
dc.contributor.authorPatwardhan, Pallavi D.-
dc.date.accessioned2023-03-31T05:28:58Z-
dc.date.available2023-03-31T05:28:58Z-
dc.date.issued2016-
dc.identifier.citationHealth Affairs, 2016, v. 35, n. 11, p. 2124-2132-
dc.identifier.issn0278-2715-
dc.identifier.urihttp://hdl.handle.net/10722/327124-
dc.description.abstractVaccines save thousands of lives in the United States every year, but many adults remain unvaccinated. Low rates of vaccine uptake lead to costs to individuals and society in terms of deaths and disabilities, which are avoidable, and they create economic losses from doctor visits, hospitalizations, and lost income. To identify the magnitude of this problem, we calculated the current economic burden that is attributable to vaccine-preventable diseases among US adults. We estimated the total remaining economic burden at approximately $9 billion (plausibility range: $4.7-$15.2 billion) in a single year, 2015, from vaccine-preventable diseases related to ten vaccines recommended for adults ages nineteen and older. Unvaccinated individuals are responsible for almost 80 percent, or $7.1 billion, of the financial burden. These results not only indicate the potential economic benefit of increasing adult immunization uptake but also highlight the value of vaccines. Policies should focus on minimizing the negative externalities or spillover effects from the choice not to be vaccinated, while preserving patient autonomy.-
dc.languageeng-
dc.relation.ispartofHealth Affairs-
dc.titleModeling the economic burden of adult vaccine-preventable diseases in the United States-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1377/hlthaff.2016.0462-
dc.identifier.pmid27733424-
dc.identifier.scopuseid_2-s2.0-84995921661-
dc.identifier.volume35-
dc.identifier.issue11-
dc.identifier.spage2124-
dc.identifier.epage2132-
dc.identifier.eissn1544-5208-
dc.identifier.isiWOS:000387503700026-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats